Other Indications

We are conducting discovery and pre-clinical research into a range of other conditions and using other engineered forms of nomacopan. Current programs include :

• The use of an engineered, targeted version of nomacopan for the treatment of other diseases such as Myasthenia Gravis where nomacopan has been engineered to target the neuromuscular junction
• Rheumatoid arthritis, where Akari recently announced pre-clinical data
• Trauma where Akari has an ongoing program